Agile’s Twirla Heads To Advisory Committee: No Mystery Why

 
• By Michael McCaughan

Contraceptive patch has had rocky regulatory path with US FDA. To Agile’s credit, the company pulls no punches in its shareholder filings in explaining the situation.

Trade union advisory committee meeting . Audience at the conference hall. Black and white shot. - Image

More from US FDA Performance Tracker

More from Regulatory Trackers